Systems and methods for treating superficial venous malformations like spider veins

Abstract

Systems and methods treat superficial venous malformations, such as spider veins. The systems and methods distribute a reactive agent, e.g., a light-reactive agent such as talaporfin sodium or verteporfin, at or near an inner wall of a vein. The systems and methods activate the reactive agent by applying energy, e.g. non-thermal light energy at a wavelength that activates the reactive agent to cause localized injury to the inner wall of the vein.

Description

RELATED APPLICATION [0001] This application is a continuation-in-part of co-pending U.S. patent application Ser. No. 11 / 446,800, filed Jun. 5, 2006 and entitled “Systems and Methods for Treating Superficial Venous Malformations Like Spider Veins,” which claims the benefit of U.S. Provisional Patent Application Ser. No. 60 / 796,656, filed May 2, 2006, and entitled “Systems and Methods for Treating Superficial Venous Malformations Like Spider Veins,” which are both incorporated herein by reference.BACKGROUND OF THE INVENTION [0002] As the large group of so-called baby-boomers advances in age, there are increasing demands for effective, non-invasive treatment of vascular diseases or dysfunctions affecting the vascular system. There are also increasing demands for non-invasive cosmetic surgery to repair conditions that have vascular origins. [0003] For example, spider veins result from various dysfunctions in the veins. Veins carry oxygen-poor blood from the body back to the heart. [0004...

AI Technical Summary

Benefits of technology

[0008] The invention provides devices, systems, methods, and protocols that provide minimally invasive, cost effective, and patient-friendly surgical and / or cosmetic surgical treatment of superficial venous malformations, e.g., spider veins.

[0009] The invention also provides devices, systems, methods, and protocols that provide minimally invasive, cost effective, and patient-friendly surgical treatment of diseases or dysfunctions in regions of the body that can be readily accessed by treatment agents carried by blood; e.g., cancers like breast and prostrate cancer; ear, nose, and throat conditions; periodontal disease; and diseases of the eye.

[0012] The devices, systems, and methods improve the quality of patient care. The devices, systems, and methods eliminate side effects such as bruising, burning, and skin discoloration. The devices, systems, and methods do not require tedious, hard to learn injection techniques. They do not require high cost trans-dermal lasers. The devices, systems, and method are usable by a large group of practitioners, such as dermatologists, phlebologists, vascular surgeons, and interventional radiologists.

Problems solved by technology

The activation of the agent causes localized injury to the inner wall of the vein.

Images